Gilead Sciences (LIM:GILD) General and Admin. Expense : $0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Gilead Sciences General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Gilead Sciences's General and Admin. Expense for the three months ended in Dec. 2023 was $0 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Gilead Sciences General and Admin. Expense Historical Data

The historical data trend for Gilead Sciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gilead Sciences General and Admin. Expense Chart

Gilead Sciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

Gilead Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
General and Admin. Expense	Get a 7-Day Free Trial															-	-	-	-	-

Gilead Sciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Gilead Sciences General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Gilead Sciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Gilead Sciences (LIM:GILD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gilead Sciences Inc (LIM:GILD) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

GILD:USA GILD:Mexico GILD:Italy GISd:UK 0QYQ:UK GIS:Germany GILD34:Brazil GILD:Austria GILD:Argentina

Address

333 Lakeside Drive, Foster, CA, USA, 94404

Website

https://www.gilead.com

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.